[Click eStock] "JLJK, Benefiting from Medical AI Market with 40% Annual Growth"

[Asia Economy Reporter Park Jihwan] Korea Investment & Securities evaluated on the 16th that JLKE is emerging as a beneficiary in the rapidly growing medical artificial intelligence market.

JLKE is a specialized medical artificial intelligence company. Its main businesses include AIHuB, which analyzes medical images such as MRI, CT, and X-ray using artificial intelligence; Hello Health, an AI-based telemedicine platform; and Hello Data, a data analysis solution utilizing artificial intelligence. The company holds 16 domestic and over 30 overseas medical AI-related licenses and certifications, and has proven its technological capabilities through more than 110 technology patents.

Researcher Jeong Songhoon of Korea Investment & Securities said, "Domestically, it has built references by partnering with more than 20 universities and large hospitals," adding, "It is also expanding its overseas presence through the establishment of local subsidiaries (in the United States and Japan) and partnerships with local companies."

JLKE’s core businesses are AI medical image analysis and non-face-to-face medical platforms. AIHuB focuses on AI medical image analysis related to the brain and cancer, such as stroke, dementia and brain aging, and prostate cancer. Hello Health is a non-face-to-face medical platform that analyzes patients’ medical images using AI and provides them to doctors to improve the accuracy and convenience of medical treatment. In May of this year, it passed the regulatory sandbox for telemedicine targeting overseas Koreans. It is expected to strengthen its business significantly once the domestic telemedicine market opens. Researcher Jeong said, "In the long term, the goal is to implement metaverse telemedicine using patients’ personal medical data such as medical images and medical AI within the metaverse."

Interest in medical AI is increasing due to the growing burden on the medical system caused by aging and the movement to improve the speed and accuracy of diagnosis. Researcher Jeong emphasized, "The medical AI market is expected to grow at an average annual rate of over 40%, from $14.7 billion in 2022 to $42 billion in 2025," and "We recommend continuous attention to JLKE, which operates related businesses."